Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
24 Apr, 2026, 08.17 AM IST
SUSE eyes deeper India push as CEO flags growth, open-source demandSUSE plans to increase investments in India, recognizing it as a significant growth market for open-source technologies. The company aims t...
22 Apr, 2026, 06.00 AM IST
Assets dip, affiliations shift: Stalin, Udhayanidhi among Tamil Nadu leaders reporting lower wealthM. K. Stalin, Udhayanidhi Stalin and other Dravida Munnetra Kazhagam leaders have reported a decline in declared assets over five years, la...
15 Apr, 2026, 05.35 PM IST
Kirti Ganorkar: Why the veteran insider is the right dose for Sun PharmaKirti Ganorkar, a long-time Sun Pharma veteran, will take over as Managing Director from September 1, succeeding founder Dilip Shanghvi, wh...
14 Jun, 2025, 11.43 PM IST
DRL's foray into medical cannabis to prompt others' entryIn December, global drug major Pfizer announced its acquisition of Arena Pharma, a medical cannabis company, for $6.7 billion. In May last ...
10 Feb, 2022, 08.25 AM IST
Bayer challenges IPAB’s compulsory licence order to Natco Pharma on cancer drug Nexavar“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said...
12 Oct, 2013, 04.01 AM IST
Pharma companies should have clear rules for business in India: GermanyBahr advocating stronger cooperation between Indian and Germany in the health sector, especially in immigration of medical and nursing prof...
29 Apr, 2013, 10.08 PM IST
- German pharma company Boehringer Ingelheim remains bullish on R&D and India
"I am quite convinced that as more and more Indian generic companies start doing their own research, I think it will change the conditions ...
15 Nov, 2012, 12.27 PM IST
- Dr Reddy's nets Rs 167 crore in Q4
Dr Reddy’s Laboratories bounced back into profit for the three months ended March, helped by the absence of any further provisioning for lo...
07 May, 2010, 01.37 AM IST
- Cipla makes cancer drug cheaper
Cipla has launched a copycat version of German pharma company Bayer’s cancer medicine Nexavar at one-tenth the price.
09 Apr, 2010, 02.53 AM IST
- Delhi High Court reject German pharma firm plea
The Delhi High Court has rejected the plea of German pharma company B Braun Melsungen AG claiming patent rights to an item sold by healthca...
13 Jul, 2009, 01.47 PM IST
- German owner taps options on Dabur Pharma delisting
German company Fresenius Kabi, which recently acquired Dabur Pharma, is learnt to be exploring the possibility of delisting the company fro...
16 Sep, 2008, 01.11 AM IST
- German firm Fresenius leads race for Dabur Pharma
Sources say that Fresenius Kabi is in advanced talks with the Indian company and has valued Dabur Pharma at over Rs 1,000 cr. Corporate Ind...
01 Apr, 2008, 04.10 AM IST
- Dabur Pharma up on possible sellout
Shares of Dabur Pharma advanced Thursday on reports that the company is looking at options like inducting a private equity investor as well...
28 Feb, 2008, 11.37 AM IST
- Dabur Pharma weighing PE partner, outright sale
The Dabur Group is learnt to be evaluating a range of options for determining the future direction of Dabur Pharma, the anti-cancer drug co...
28 Feb, 2008, 12.52 AM IST
- Foreign players look at India to develop lower-cost drugs
German pharma major Boehringer Ingelheim is close to completing its first in-licensing deal with an Indian pharmaceutical company.
23 May, 2007, 12.18 AM IST
- Merck inks pact to develop, sell Glenmark diabetes drug
German pharma major Merck KGaA and Glenmark Pharmaceuticals SA (Switzerland), a wholly-owned subsidiary of Glenmark Pharma India, announced...
18 Oct, 2006, 02.40 AM IST